A drug rollout that officials hailed as a demonstration that the UK was still a “science superpower,” has reached only a ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...
HealthTab™ enters secondary-prevention care inside the NHS — a major expansion from screening into therapy-linked workflows. Integration with Ortus-iHealth connects HealthTab directly into hospital ...
Integration with Ortus-iHealth connects HealthTab directly into hospital clinical systems, positioning the platform as core infrastructure for NHS pharmacy-based care. Strengthens Avricore’s position ...
Supported by a £198,000 BHF grant, the pilot reflects growing momentum toward decentralizing cardiovascular therapy delivery and reducing hospital burden by shifting appropriate services into ...
VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company " or “Avricore ”) is pleased to announce HealthTab™ is being deployed in a new pilot ...
(MENAFN- GlobeNewsWire - Nasdaq) Bringing Cholesterol-Lowering Injections to U.K. Community Pharmacies HealthTabTM enters secondary-prevention care inside the NHS - a major expansion from screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback